Compare ARCO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCO | PGEN |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2011 | N/A |
| Metric | ARCO | PGEN |
|---|---|---|
| Price | $7.38 | $4.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $8.60 | $7.67 |
| AVG Volume (30 Days) | 900.9K | ★ 4.8M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ 69.06 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,555,936,000.00 | $6,309,000.00 |
| Revenue This Year | $6.35 | $342.78 |
| Revenue Next Year | $7.64 | $478.46 |
| P/E Ratio | $6.29 | ★ N/A |
| Revenue Growth | 1.21 | ★ 59.20 |
| 52 Week Low | $6.51 | $0.69 |
| 52 Week High | $8.52 | $5.23 |
| Indicator | ARCO | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.36 | 55.67 |
| Support Level | $7.09 | $3.96 |
| Resistance Level | $7.40 | $4.54 |
| Average True Range (ATR) | 0.14 | 0.28 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 57.45 | 66.07 |
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.